Ocular Therapeutix OCUL
NASDAQ OCUL
$6.50 -0.11 (-1.66%)
At close: Oct 23, 2026 · 4:00 PM EDT

Ocular Therapeutix (OCUL) Purchase of Investments (2015 - 2017)

Updated

Analysis

Ocular Therapeutix (OCUL) Purchase of Investments (2015 - 2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Purchased (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 307.00 Mn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 919.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 834.00 Mn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 148.00 Mn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 46.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 42.00 Mn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.54 Bn
10 Ocular Therapeutix 1.43 Bn -919.84 Mn 11.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 3.00 Mn
Dec 31, 2016 27.70 Mn
Sep 30, 2016 2.50 Mn
Dec 31, 2015 16.67 Mn
Sep 30, 2015 57.51 Mn
Mar 31, 2015 17.50 Mn
API Access

Ocular Therapeutix Purchase of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=purchase-of-investments&ticker=OCUL&period=max&api_key=YOUR_API_KEY